Quest Diagnostics Incorporated DGX

236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Quest Diagnostics Incorporated (DGX) EV/Sales

As of 25 September 2026, Quest Diagnostics Incorporated (DGX) trades at a EV/Sales of 2.7×. Over the past ten years it has ranged from 1.6× (September 2015) to 2.8× (September 2026); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 5.7× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 2.2× (2.16%)
FY2024 2.3× 6.09%
FY2023 2.1× (2.69%)
FY2022 2.2× (4.20%)
FY2021 2.3× 15.08%
FY2020 2.0× (13.84%)
FY2019 2.3× 15.60%
FY2018 2.0× (13.79%)
FY2017 2.3× 2.71%
FY2016 2.3× 23.16%

Quarterly

Period EV/Sales Change
Jun 2026 2.5× 3.82%
Mar 2026 2.4× 7.06%
Dec 2025 2.2× (9.35%)
Sep 2025 2.5× 1.22%
42 more quarters

Against its own ten years

Low 1.6× High 2.8×
Ten-year median 2.1×
Current reading's percentile 99

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated 2.7×
MEDP Medpace Holdings, Inc. compare 6.1×
RVTY Revvity Inc. compare 6.5×
MTD Mettler-Toledo International, Inc. compare 7.9×
IDXX IDEXX Laboratories, Inc. compare 9.1×
ILMN Illumina, Inc. compare 9.3×
WAT Waters Corporation compare 10.1×
GH Guardant Health, Inc. compare 20.3×
Diagnostics & Research industry median 5.7×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on DGX